Selected research
Industry Research
Ornithine Aspartate Industry Research Report 2026
Market perspective
The global Ornithine Aspartate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ornithine Aspartate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ornithine Aspartate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ornithine Aspartate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ornithine Aspartate include Dexa Medica, Kyowa Hakko, Merz Pharma, Shin Poong Pharmaceutical, TCI America, Qi Rui Yao Ye and Yibin Pharmacy, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ornithine Aspartate market in terms of revenue (US$ million) and, where applicable, sales volume (g), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/g) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ornithine Aspartate Market by Company
Dexa Medica
Kyowa Hakko
Merz Pharma
Shin Poong Pharmaceutical
TCI America
Qi Rui Yao Ye
Yibin Pharmacy
Ornithine Aspartate Segment by Type
Powder Injection
Granules
Water Injection
Other
Ornithine Aspartate Segment by Application
Hepatic Encephalopathy
Hepatitis
Post-hepatitis Syndrome
Liver Cirrhosis
Fatty Liver
Other
Ornithine Aspartate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ornithine Aspartate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ornithine Aspartate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ornithine Aspartate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ornithine Aspartate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ornithine Aspartate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ornithine Aspartate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Powder Injection
- Granules
- Water Injection
- Other
Applications
- Hepatic Encephalopathy
- Hepatitis
- Post-hepatitis Syndrome
- Liver Cirrhosis
- Fatty Liver
- Other
Companies covered
- Dexa Medica
- Kyowa Hakko
- Merz Pharma
- Shin Poong Pharmaceutical
- TCI America
- Qi Rui Yao Ye
- Yibin Pharmacy
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ornithine Aspartate Market Size (2021-2032)
- 2.2.2 Global Ornithine Aspartate Sales (2021-2032)
- 2.2.3 Global Ornithine Aspartate Market Average Price (2021-2032)
- 2.3 Ornithine Aspartate by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Powder Injection
- 2.3.3 Granules
- 2.3.4 Water Injection
- 2.3.5 Other
- 2.4 Ornithine Aspartate by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hepatic Encephalopathy
- 2.4.3 Hepatitis
- 2.4.4 Post-hepatitis Syndrome
- 2.4.5 Liver Cirrhosis
- 2.4.6 Fatty Liver
- 2.4.7 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ornithine Aspartate Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ornithine Aspartate Sales (g) of Manufacturers (2021-2026)
- 3.3 Global Ornithine Aspartate Revenue of Manufacturers (2021-2026)
- 3.4 Global Ornithine Aspartate Average Price by Manufacturers (2021-2026)
- 3.5 Global Ornithine Aspartate Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ornithine Aspartate, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ornithine Aspartate, Product Type & Application
- 3.8 Global Manufacturers of Ornithine Aspartate, Established Date
- 3.9 Global Ornithine Aspartate Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Dexa Medica
- 4.1.1 Dexa Medica Company Information
- 4.1.2 Dexa Medica Business Overview
- 4.1.3 Dexa Medica Ornithine Aspartate Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Dexa Medica Ornithine Aspartate Product Portfolio
- 4.1.5 Dexa Medica Recent Developments
- 4.2 Kyowa Hakko
- 4.2.1 Kyowa Hakko Company Information
- 4.2.2 Kyowa Hakko Business Overview
- 4.2.3 Kyowa Hakko Ornithine Aspartate Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Kyowa Hakko Ornithine Aspartate Product Portfolio
- 4.2.5 Kyowa Hakko Recent Developments
- 4.3 Merz Pharma
- 4.3.1 Merz Pharma Company Information
- 4.3.2 Merz Pharma Business Overview
- 4.3.3 Merz Pharma Ornithine Aspartate Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merz Pharma Ornithine Aspartate Product Portfolio
- 4.3.5 Merz Pharma Recent Developments
- 4.4 Shin Poong Pharmaceutical
- 4.4.1 Shin Poong Pharmaceutical Company Information
- 4.4.2 Shin Poong Pharmaceutical Business Overview
- 4.4.3 Shin Poong Pharmaceutical Ornithine Aspartate Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Shin Poong Pharmaceutical Ornithine Aspartate Product Portfolio
- 4.4.5 Shin Poong Pharmaceutical Recent Developments
- 4.5 TCI America
- 4.5.1 TCI America Company Information
- 4.5.2 TCI America Business Overview
- 4.5.3 TCI America Ornithine Aspartate Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 TCI America Ornithine Aspartate Product Portfolio
- 4.5.5 TCI America Recent Developments
- 4.6 Qi Rui Yao Ye
- 4.6.1 Qi Rui Yao Ye Company Information
- 4.6.2 Qi Rui Yao Ye Business Overview
- 4.6.3 Qi Rui Yao Ye Ornithine Aspartate Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Qi Rui Yao Ye Ornithine Aspartate Product Portfolio
- 4.6.5 Qi Rui Yao Ye Recent Developments
- 4.7 Yibin Pharmacy
- 4.7.1 Yibin Pharmacy Company Information
- 4.7.2 Yibin Pharmacy Business Overview
- 4.7.3 Yibin Pharmacy Ornithine Aspartate Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Yibin Pharmacy Ornithine Aspartate Product Portfolio
- 4.7.5 Yibin Pharmacy Recent Developments
5 Global Ornithine Aspartate Market Scenario by Region
- 5.1 Global Ornithine Aspartate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ornithine Aspartate Sales by Region: 2021-2032
- 5.2.1 Global Ornithine Aspartate Sales by Region: 2021-2026
- 5.2.2 Global Ornithine Aspartate Sales by Region: 2027-2032
- 5.3 Global Ornithine Aspartate Revenue by Region: 2021-2032
- 5.3.1 Global Ornithine Aspartate Revenue by Region: 2021-2026
- 5.3.2 Global Ornithine Aspartate Revenue by Region: 2027-2032
- 5.4 North America Ornithine Aspartate Market Facts & Figures by Country
- 5.4.1 North America Ornithine Aspartate Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ornithine Aspartate Sales by Country (2021-2032)
- 5.4.3 North America Ornithine Aspartate Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Ornithine Aspartate Market Facts & Figures by Country
- 5.5.1 Europe Ornithine Aspartate Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ornithine Aspartate Sales by Country (2021-2032)
- 5.5.3 Europe Ornithine Aspartate Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Ornithine Aspartate Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ornithine Aspartate Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ornithine Aspartate Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ornithine Aspartate Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ornithine Aspartate Market Facts & Figures by Country
- 5.7.1 South America Ornithine Aspartate Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ornithine Aspartate Sales by Country (2021-2032)
- 5.7.3 South America Ornithine Aspartate Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Ornithine Aspartate Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ornithine Aspartate Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ornithine Aspartate Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ornithine Aspartate Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Ornithine Aspartate Sales by Type (2021-2032)
- 6.1.1 Global Ornithine Aspartate Sales by Type (2021-2032) & (g)
- 6.1.2 Global Ornithine Aspartate Sales Market Share by Type (2021-2032)
- 6.2 Global Ornithine Aspartate Revenue by Type (2021-2032)
- 6.2.1 Global Ornithine Aspartate Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ornithine Aspartate Revenue Market Share by Type (2021-2032)
- 6.3 Global Ornithine Aspartate Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ornithine Aspartate Sales by Application (2021-2032)
- 7.1.1 Global Ornithine Aspartate Sales by Application (2021-2032) & (g)
- 7.1.2 Global Ornithine Aspartate Sales Market Share by Application (2021-2032)
- 7.2 Global Ornithine Aspartate Revenue by Application (2021-2032)
- 7.2.1 Global Ornithine Aspartate Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ornithine Aspartate Revenue Market Share by Application (2021-2032)
- 7.3 Global Ornithine Aspartate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ornithine Aspartate Value Chain Analysis
- 8.1.1 Ornithine Aspartate Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ornithine Aspartate Production Mode & Process
- 8.2 Ornithine Aspartate Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ornithine Aspartate Distributors
- 8.2.3 Ornithine Aspartate Customers
9 Global Ornithine Aspartate Analyzing Market Dynamics
- 9.1 Ornithine Aspartate Industry Trends
- 9.2 Ornithine Aspartate Industry Drivers
- 9.3 Ornithine Aspartate Industry Opportunities and Challenges
- 9.4 Ornithine Aspartate Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst